Researchers at the University of Cambridge have developed a new type of smart material capable of sensing changes in the internal human environment and releasing drugs under specific conditions. The material was developed by the team led by Professor Oren Scherman from the Yusuf Hamied Department of Chemistry at the University of Cambridge. Its properties enable it to respond to subtle pH changes in the joints during arthritis flare-ups.
This flexible material adopts a specially designed polymer network structure. When it detects an increase in acidity caused by inflammation, the material changes its physical state and releases the encapsulated drug molecules. In laboratory tests, the research team used fluorescent dyes to simulate drug behavior and confirmed that the material released significantly more drug under the typical acidic conditions of arthritis compared to normal physiological conditions. The research results have been published in the Journal of the American Chemical Society.
Professor Scherman stated: "Combining material properties with targeted drug delivery shows promising application prospects." This smart responsive material system is entirely driven by the body's own chemical reactions and does not require external triggering devices. First author Dr. Stephen O'Neill pointed out: "This material can sense abnormalities in the body and respond accordingly, delivering treatment precisely where it is needed. It has the potential to reduce medication frequency and improve patients' quality of life."
In the UK, arthritis affects approximately 10 million people, with related expenditures by the National Health Service reaching £10.2 billion annually. Globally, more than 600 million people suffer from arthritis. Current treatment methods mainly rely on systemic drug administration, which may cause side effects. This new smart responsive material offers a potential solution for achieving localized and precise drug delivery.
Co-author of the paper, Dr. Jed McCune, added: "By adjusting the chemical properties of the gel, we can make it highly sensitive to acidity changes in inflamed tissues, ensuring that the drug is released at the right time and place where it is most needed." The researchers noted that, with appropriate modifications, this method could be applied to various medical scenarios.
The research team's next step will be to further test the material's performance and safety in biological systems. If successful, this technology will open new pathways for the treatment of chronic diseases and promote the development of responsive biomaterials.
